Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 26,195
-485 (-1.82%)
Nov 11, 2026, 1:03 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 555.96 billion as of November 10, 2026. Its market cap has decreased by 11.30% in one year.
Market Cap
555.96B
Enterprise Value
541.96B
Revenue
71.98B
Global Rank
n/a
Country Rank
n/a
PE Ratio
33.68
ChartMarket Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 555.96B, an increase of 11,557.17%. That is a compound annual growth rate of 21.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 555.96B | -10.00% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.14T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 730.90B |
| Alkem Laboratories | 633.34B |
| Gland Pharma | 522.88B |
| Ipca Laboratories | 491.73B |
| Emcure Pharmaceuticals | 419.19B |